The goal of thromboprophylaxis is to prevent both the occurrence and the consequences of deep vein thrombosis. [1] General measures to reduce the risk of venous thromboembolism in older patients ...

Clinical guidelines recommend low-molecular-weight heparin for thromboprophylaxis in patients with fractures, but trials of its effectiveness as compared with aspirin are lacking. In this pragmatic, ...

This phase 3 trial compared the efficacy and safety of rivaroxaban, an oral direct inhibitor of factor Xa, with those of enoxaparin for extended thromboprophylaxis in patients undergoing total hip ...

Please provide your email address to receive an email when new articles are posted on . The 1986 National Institutes of Health consensus conference Prevention of Venous Thrombosis and Pulmonary ...

Please provide your email address to receive an email when new articles are posted on . TAMPA, Fla. —Aspirin as a thromboprophylaxis agent was noninferior to low-molecular-weight heparin for all-cause ...